Monographie - Paracetamol

最新更新 :
28/04/2024

Paracetamol

化学構造

商品名

商品名、賦形剤は国、製薬会社ごとに異なることがあります

Apotel	イラン, ギリシア
Axapara	エクアドル
Eupifalgan	エジプト
Febrinil	インド
Feveril	エクアドル
Flashmol	チリ
Imitimol	チリ
Injectmol	エジプト
Ofirmev	アメリカ
Paraconica	スイス
Parasedol	トルコ
Parol	トルコ
Partemol	トルコ
Perfalgan	アイスランド, アイルランド, アラブ首長国連邦, イギリス, イタリア, エジプト, オランダ, オーストリア, サウジアラビア, スイス, スウェーデン, スペイン, チュニジア, デンマーク, トルコ, ドイツ, ニュージーランド, ノルウェー, フィンランド, フランス, ポルトガル, ポーランド, ルーマニア
Perfusalgan	ベルギー, ルクセンブルグ
Raziphemol	エジプト, ベルギー, ルクセンブルグ
Tempra	メキシコ
Vedraphen	エジプト

引用文献 : Paracetamol

	形式	出版物
150	雑誌	Aujoulat P, Coze C, Braguer D, Raybaud C. Physicochemical compatibility of methotrexate with co-administered drugs during cancer chemotherapy regimens. J Pharm Clin 1993 ; 12: 31-35.
2122	雑誌	Kambia NK, Luyckx M, Dine T, Dupin-Sriet T, Gressier B, Brunet C. Stability and compatibility of paracetamol injection admixed with ketoprofen. EJHP Science 2006 ; 12, 4: 81-84.
2140	雑誌	Kambia NK, Luyckx M, Dine T, Dupin-Spriet T, Gressier B, Brunet C. Stability and compatibility of the ready-to-use solution of paracetamol admixted with phloroglucinol for intravenous infusion. EJHP Science 2006 ; 12, 5: 91-95.
2231	雑誌	de Jongh R, Hens R, Basma V, mouton JW, Tulkens PM, Carryn S. Continuous versus intermittent infusion of temocillin, a directed spectrum penicillin for intensive care patients with nosocomial pneumonia: stability, compatibility, population pharmacokinetic studies and breakpoint selection. J Antimicrob Chemother 2008 ; 61, 2: 382-388.
3075	雑誌	Balayssac D, Badaroux L, Rodier C, Sautou-Miranda V, Bazin JE, Chopineau J. Compatibility and stability of parenteral analgesic admixtures for multimodal analgesia EJHP Science 2009 ; 15, 4: 78-82.
3315	ポスター	Louvrier M, Dhennain S, Hocahrt S, Zawadski E, Bouffart S, Moquay E. Mise en évidence d'une incompatibilité physico-chimique entre la phénytoïne sodique et le paracétamol injectable en flacon. Communication orale Hopipharm 2012
3350	雑誌	Kwiatkowski J.L, Johnson C.E, Wagner D.S. Extended stability of intravenous acetaminophen in syringes and opened vials. Am J Health-Syst Pharm 2012 ; 69:1999-2001
3372	雑誌	Hanci V, Ali Kiraz H, Ömür D, Ekin S, Uyan B, Yurtlu B.S. Precipitation in Gallipoli: Sugammadex / Amiodarone & Sugammadex / Dobutamine & Sugammadex / Protamine. Rev Bras Anestesiol 2013 ; 63, 1: 163-166.
3571	雑誌	Anderson C, Boehme S, Ouellette J, Stidham C, MacKay M. Physical and Chemical Compatibility of Injectable Acetaminophen During Simulated Y-Site Administration. Hosp Pharm 2014 ; 49, 1: 42-47.
3728	雑誌	Correard F, Savry A, Gauthier-Villano L, Pisano P, Pourroy B. Visual compatibility of defibrotide with selected drugs during simulated Y-site administration. Am J Health-Syst Pharm 2014 ; 71: 1288-1291.
3769	実験	Paracatamol (Paracetamol B Braun®) - Résumé des caractéristiques du produit B Braun laboratoire 2014
3824	雑誌	Boudi S, Roy H, Forest JM, Leclair G. Compatibilité physique de l'association amoxicilline-acide clavulanique en injection avec plusieurs autres médicaments lors d'une administration en Y. Pharmactuel 2023 2023;56,3:91-98
3879	雑誌	Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace Edward E. Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures. Int J Pharm Compound 2016 ; 20, 4 : 328-332.
3948	雑誌	Bouchoud L, Fonzo-Christe C, Klingm?ller M, Bonnabry P . Compatibility of Intravenous Medications With Parenteral Nutrition - In Vitro Evaluation. JPEN 2012 ;30. 416?424.
3967	雑誌	Staven V, Herra I, Wang S, Grönlie I,Tho I. Physical compatibility of total parenteral nutrition and drugs in Y-site administration to children from neonates to adolescents. J Pharm Pharmacol 2017 ;69,7:448-462
3976	雑誌	Du Repaire T, Vigne P, Guedon A, Gauthier-Villano L, Bertault Peres P, Pourroy B. Visual compatibility of blinatumomab with selected co-administrated drugs during simulated Y-site administration. Am J Health-Syst Pharm 2017 ; 74,16 : 1217-1218
3985	ポスター	Manai M., Soussi M.A., Lazreg O., Drira C., Ben Tekaya S. et Razgallah Khrouf M. Compatibilité physique entre médicaments injectables et nutrition parentérale pédiatrique : Evaluation in-vitro. Hopipharm Congress 2017 - Nancy 2017
4362	雑誌	Lopez Navarro AA, Martinez Gomez MA, Gras Colomer E, Campillos P, Climente Marti M. Physicochemical stability of binary admixtures of paracetamol and dexketoprofen-trometamol for patient-controlled analgesia use. EJHP 2018 Eur J Hosp Pharm 2018;0:1
4435	雑誌	Hanifah S, Nugroho B.H, Chabib L. Compatibility of acetaminophen with central nervous system medications during simulated Y-site injection. Anaesthesiol Intensive Ther 2020 ; 52, 1: 23-27.
4465	雑誌	Foushee A, Meredith P, Fox Laura, Wilder A. Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients. Am J Health-Syst Pharm 2020 ;77,14:1144-1148
4488	雑誌	Nezvalova-Henriksen K, Niklas Nilsson N, Tomine Østerberg C, Staven Berge V, Tho I. Y-Site Physical Compatibility of Numeta G13E with Drugs Frequently Used at Neonatal Intensive Care. Pharmaceutics 2020 ; 12, 677.
4521	雑誌	Polo C, D’Huart E, Lesperlette G, Vigneron J, Meyer F, Demoré B. Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit. Pharmaceutical Technology in Hospital Pharmacy 2020
4543	雑誌	Senarathna G, Strunk T, Petrovski M, Batty K. Physical compatibility of pentoxifylline and intravenous medications. Archives of Disease in Childhood 2018 ;104:292–295.
4642	ポスター	Larossa garcia M, Jimenez-Lozano I, Boix-Montanés A, Mallandrich Miret M, Clemente Bautista M, cabanas Poy M.J., Gorgas Torner Compatibilidad en Y de atosiban y farmacois habitualmente utilizados en obstetricia. SEFH Congress (Virtual) October 2021 2021
4698	雑誌	Ayari G, D'Huart E, Vigneron J, Demoré B. Y-site compatibility of intravenous medications commonly used in intensive care units : laboratory tests on 75 mixtures involving nine main drugs. Pharmaceutical Technology in Hospital Pharmacy 2022
4742	雑誌	Macoviciuc M, Nguyen C, Forest J-M, Leclair G. Compatibilité physique de l’acétaminophène injectable avec 102 autres médicaments lors d’une administration en Y. Pharmactuel 2022 ; 55, 4: 247-255.

Mentions Légales